DTC Limits May Land In Court After Opponents Fail To Strip FDA Powers From Bill

The restrictions on direct-to-consumer advertising placed in the legislation to renew the prescription drug user fee program appear headed towards a showdown in the judicial branch after an attempt to remove them failed in a Senate committee